Evaluating App-Based Vision Testing (WHOeyes) Combined With the Questionnaire as a Substitute for One-Week Postoperative In-Clinic Follow-Up in Age-Related Cataract Patients: A Multi-center Randomized Controlled Trial
Key facts
- Who runs it
- Zhongshan Ophthalmic Center, Sun Yat-sen University
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Enrolling by invitation
- People taking part
- 334 people, planned
- Started
- 9 Dec 2024
- Planned end
- Jun 2026
- Type of study
- Interventional, 2 groupsOne group gets no study treatment, for comparison.
- Treatments tested
- WHOeyes combined with a questionnaire.
- Record updated
- 9 April 2026
Who can take part
- Age
- 50 years to 80 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 14 criteriaShow less
Who can take part
- Senile cataract patients undergoing Phaco + IOL implantation under local anesthesia
- Between 50 and 80 years of age, regardless of gender
- The subject or their family members own a smartphone, understand and can correctly install and use the WHOeyes app for vision testing under the guidance of a physician
- Able to understand and cooperate with the trial procedures, voluntarily participate in this clinical trial, and sign an informed consent form
Who cannot take part
- Scheduled ocular surgery in either eye during the study period, such as trabeculectomy, corneal transplantation
- Occurrences of intraoperative and postoperative complications (e.g., elevated intraocular pressure, corneal edema) in the study eye within 1 day after cataract surgery
- Participation in other clinical trials within the last 30 days (excluding those who only participated in screening process without receiving any investigational drugs or devices)
- History of ocular trauma in the study eye
- History of ocular surgery in the study eye, such as glaucoma surgery, vitrectomy, corneal refractive surgery, corneal transplantation
- Any other condition or circumstance that, in the investigator's judgment, makes the patient unsuitable for participation in this trial; Note: The study eye refers to the eye that underwent cataract surgery and is included in this study
- With severe chronic systemic diseases or are susceptible to infection, including:; Poorly controlled diabetes (fasting blood glucose >10 mmol/L); Poorly controlled hypertension (systolic blood pressure>160mmHg or diastolic blood pressure>100mmHg); Ongoing systemic treatment for infectious diseases; Presence of cachexia or bone marrow suppression; Confirmed diagnosis of AIDS or positive test results for HIV antibodies; Presence of severe cardiovascular, pulmonary, hepatic, renal, endocrine, immune, dermatological, musculoskeletal, neurological, or psychiatric diseases, hearing impairment, or mobility impairment, as deemed unsuitable for participation in this trial by the investigator
- Had other serious eye diseases in addition to cataract, including:; Chronic or recurrent eye diseases of the study eye, such as keratitis or corneal malnutrition, iritis, scleritis, uveitis, iridocyclitis. (Note: refractive errors, dry eye, chronic conjunctivitis, and mild pterygium are not exclusionary; Active ocular infection or inflammation in either eye; Episode of acute uveitis within the past 6 months in either eye; Intraocular pressure >21mmHg or a history of glaucoma in the study eye; Presence of unstable active lesions or other ocular diseases of the study eye that, in the investigator's judgment, could potentially interfere with the study evaluation or compromise subject safety (e.g., moderate to severe diabetic retinopathy, wet age-related macular degeneration, retinal detachment); Congenital abnormalities in the study eye (e.g., congenital cataracts, aniridia); Corrected visual acuity in the non-study eye <0.1 (20/200)
- Corrected visual acuity of the study eye less than 0.5 (20/40) on postoperative day 1
- Have pre-planned hospital visits during the study period, other than those required for postoperative follow-ups of the study eye
The main criteria, as questions
These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.
- Are you between 50 and 80 years old?
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
The goal of this clinical trial is to learn if an app-based vision testing (WHOeyes) combined with a questionnaire can recognize those who have to go back to the hospital, and thus replace the in-clinic 1-week review after an uncomplicated cataract surgery in people with senile cataract. It will also learn about the cost-effectiveness and environmental benefits of such remote follow-up pattern. Besides, the safety and user's satisfaction will also be evaluated. The main questions it aims to answer are:
Read full original descriptionShow less
For people with uncomplicated senile cataract, does 1-week clinical follow-up replaced with remote follow-up (using a vision test app and a questionnaire) not adversely affect patients' prognosis? Can this alternative approach bring greater cost-effectiveness and environmental friendliness compared to the traditional follow-up method? Researchers will compare one-week remote follow-up to a routine clinical follow-up to see if one-week remote follow-up is feasible.
Participants will:
Visit the clinic to finish routine follow-up 1 day and 1 month after cataract surgery.
Using app (WHOeyes) and a questionnaire at home or visit the clinic 1 week after cataract surgery.
The 2 groups in the trial
- Remote follow-upTreatment being tested
One week postoperatively, the participants use the WHOeyes app to test their uncorrected visual acuity and fill in a self-made discomfort identification questionnaire. Visit the clinics for review 1 day and 1 month post-cataract surgery.
Treatment: WHOeyes combined with a questionnaire.
- Usual careNo study treatment, for comparison
Participants routinely returned to the hospital for review 1 day, 1 week and 1 month post-cataract surgery
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Criteria questions
- Built from NCT06429527, who can take part
- Record updated
- 9 April 2026